Loading
Aier Eye Hospital Group Co., Ltd. Stock: price and insider trades · China
爱尔眼科
No insider purchase over the last 90 days. The latest, by 唐仕波, was filed 15 Jul 2022.
Insider Decl.
49
Thresholds
n/a
Buy Volume
€10M
49 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -28.6%Entry CN¥26.77 · Close at T+365 CN¥19.11
- -28.2%Entry CN¥26.44 · Close at T+365 CN¥18.99
- -9.0%Entry CN¥22.47 · Close at T+365 CN¥20.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Aier Eye Hospital Group Co., Ltd. Buy (bullish), based on 12 analysts. Average price target: CN¥12.19.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,916 of 26,284 companies
63.5
score / 100
Value56
Quality71
FCF yld5.3%
Earn yld4.4%
EV/EBITDA12.5x
ROE12%
Gross mgn47%
Net mgn14%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥7.93
Analyst consensus
12 analystsBuy
CN¥8.10Target CN¥12.19(+54%)CN¥15.79
Income statement
RevenueCN¥22.4B
Gross profitCN¥10.5B47% margin
EBITDACN¥6.5B29% margin
Net incomeCN¥3.2B11.2% margin
Valuation
PER (trailing)29.4x
PER (forward)17.8x
P/Book3.2x
Beta0.47
Balance sheet & cash
Market capCN¥73.7B
Total debtCN¥7.2B
Free Cash FlowCN¥3.9B
Debt / Equity31%
Profitability & ownership
ROE11.8%
ROA8.5%
% insiders54.4%
% institutions6.0%
Last declaration on 15 July 2022
Declarations49 total
5,000 shares50.1% of flowA股XSHESZSE:173000005689829440
Canonical exit: 13 Oct 2022 (T+90)
5,000 shares49.9% of flowA股XSHESZSE:173000005681551840
Canonical exit: 12 Oct 2022 (T+90)
150,000 shares11.9% of flowA股XSHESZSE:173000005649177630
Canonical exit: 29 Sept 2022 (T+90)
54,700 shares4.4% of flowA股XSHESZSE:173000005641036200
Canonical exit: 28 Sept 2022 (T+90)
114,400 shares8.4% of flowA股XSHESZSE:173000005614950050
Canonical exit: 21 Sept 2022 (T+90)
200,000 shares14.7% of flowA股XSHESZSE:173000005610978700
Canonical exit: 19 Sept 2022 (T+90)
150,000 shares10.3% of flowA股XSHESZSE:173000005605692350
Canonical exit: 15 Sept 2022 (T+90)
99,500 shares6.8% of flowA股XSHESZSE:173000005599321340
Canonical exit: 14 Sept 2022 (T+90)
15,000 shares7.7% of flowA股XSHESZSE:173000005595967330
Canonical exit: 13 Sept 2022 (T+90)
10,000 shares4.9% of flowA股XSHESZSE:173000005585460670
Canonical exit: 8 Sept 2022 (T+90)
5,000 shares2.5% of flowA股XSHESZSE:173000005581163970
Canonical exit: 7 Sept 2022 (T+90)
2,000 shares1.0% of flowA股XSHESZSE:173000005578660200
Canonical exit: 6 Sept 2022 (T+90)
5,000 shares2.4% of flowA股XSHESZSE:173000005564436580
Canonical exit: 30 Aug 2022 (T+90)
100,600 shares6.6% of flowA股XSHESZSE:173000005564436540
Canonical exit: 30 Aug 2022 (T+90)
10,000 shares4.6% of flowA股XSHESZSE:173000005560793300
Canonical exit: 29 Aug 2022 (T+90)
3,000 shares1.3% of flowA股XSHESZSE:173000005555753570
Canonical exit: 25 Aug 2022 (T+90)
1,000 shares0.5% of flowA股XSHESZSE:173000005552239070
Canonical exit: 24 Aug 2022 (T+90)
4,000 shares1.8% of flowA股XSHESZSE:173000005547832130
Canonical exit: 22 Aug 2022 (T+90)
2,000 shares0.9% of flowA股XSHESZSE:173000005545391140
Canonical exit: 21 Aug 2022 (T+90)
1,000 shares0.5% of flowA股XSHESZSE:173000005542928000
Canonical exit: 18 Aug 2022 (T+90)
5,000 shares2.3% of flowA股XSHESZSE:173000005522950560
Canonical exit: 10 Aug 2022 (T+90)
2,000 shares1.0% of flowA股XSHESZSE:173000005503421700
Canonical exit: 28 Jul 2022 (T+90)
2,000 shares1.0% of flowA股XSHESZSE:173000005491228640
Canonical exit: 27 Jul 2022 (T+90)
2,000 shares0.8% of flowA股XSHESZSE:173000005426655680
Canonical exit: 23 Jun 2022 (T+90)
50,000 shares2.7% of flowA股XSHESZSE:173000005428938720
Canonical exit: 22 Jun 2022 (T+90)
25 of 49 declarations
About Aier Eye Hospital Group Co., Ltd.
爱尔眼科 (Aier Eye Hospital Group Co., Ltd.), a Chinese health care group valued at CNY 73.7 billion and 54.4% held by its insiders, has a record that sits entirely in 2022: 49 filings, all purchases, published between January 6, 2022 and July 15, 2022, worth EUR 10.1 million in total with a median of EUR 44,610. No sale is reported and no filing falls within the last twelve months.
Four filers share the record. 吴士君 (董秘,董事,高管) signed 31, 李力 (董事,高管) 13, 刘多元 3 and 唐仕波 2. The three largest purchases are 李力's: EUR 1,289,601 on January 21, 2022, EUR 1,146,920 on June 21, 2022 and EUR 928,096 on July 1, 2022.
Read moreShow less
Between June 15, 2022 and July 15, 2022, 3 filers bought EUR 4,544,679 worth. Across the full history, 40 purchase filings are classed as clustered. The median publication delay is 0 days. For 49 purchases the stored 90-day median is 3.9% (61% of results positive), recorded past results and not a forecast.
